Vitamin D3 1000 IU
Natural health product licensed in Canada
- Licence holder
- Hiral Labs Ltd.
- NPN or DIN-HM
- 80043136
- Status
- Active licence
- Licence date
- 24 June 2013
- Revision date
- 23 November 2021
- Form
- Comprimé
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Calcium phosphate dibasic, Hypromellose, Dioxyde de titane, Hydroxypropylcellulose, Talc, Colloidal silicon dioxide, (p)-hydroxybenzoate de propyl sodium, Carboxyméthylcellulose de sodium, Stéarate de magnésium, Cellulose microcristalline, Povidone
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in the maintenance of good health. Helps in the maintenance of good health. Helps in the absorption and use of calcium and phosphorus.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80043136
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging